Biofrontera AG
BFFTF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $34,071 | $28,674 | $24,100 | $18,849 |
| % Growth | 18.8% | 19% | 27.9% | – |
| Cost of Goods Sold | $17,444 | $15,185 | $12,742 | $9,066 |
| Gross Profit | $16,627 | $13,489 | $11,358 | $9,783 |
| % Margin | 48.8% | 47% | 47.1% | 51.9% |
| R&D Expenses | $77 | $0 | $0 | $0 |
| G&A Expenses | $39,127 | $35,870 | $25,459 | $18,117 |
| SG&A Expenses | $39,127 | $35,870 | $25,959 | $18,117 |
| Sales & Mktg Exp. | $0 | $0 | $500 | $0 |
| Other Operating Expenses | $100 | $33 | $689 | $0 |
| Operating Expenses | $39,959 | $35,870 | $37,209 | $18,117 |
| Operating Income | -$22,677 | -$22,381 | -$25,851 | -$8,334 |
| % Margin | -66.6% | -78.1% | -107.3% | -44.2% |
| Other Income/Exp. Net | $2,560 | $17,973 | -$12,456 | -$2,589 |
| Pre-Tax Income | -$20,117 | -$608 | -$37,657 | -$10,923 |
| Tax Expense | $14 | $32 | $56 | $64 |
| Net Income | -$20,131 | -$640 | -$37,713 | -$10,987 |
| % Margin | -59.1% | -2.2% | -156.5% | -58.3% |
| EPS | -13.02 | -0.61 | -44.1 | -18.94 |
| % Growth | -2,034.4% | 98.6% | -132.8% | – |
| EPS Diluted | -13.02 | -0.61 | -44.1 | -18.94 |
| Weighted Avg Shares Out | 1,546 | 1,057 | 855 | 580 |
| Weighted Avg Shares Out Dil | 1,546 | 1,057 | 855 | 580 |
| Supplemental Information | – | – | – | – |
| Interest Income | $132 | $175 | $16 | $28 |
| Interest Expense | $600 | $195 | $360 | $2,897 |
| Depreciation & Amortization | $1,064 | $1,172 | $540 | $562 |
| EBITDA | -$18,453 | $934 | -$36,757 | -$7,492 |
| % Margin | -54.2% | 3.3% | -152.5% | -39.7% |